-
1
Ospemifene for vulvar and vaginal atrophy: an overview
Published 2020-07-01“…Drugs in Context…”
Get full text
Article -
2
Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guideli...
Published 2023-11-01“…Drugs in Context…”
Get full text
Article -
3
Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)
Published 2023-01-01“…Drugs in Context…”
Get full text
Article -
4
The magnitude and predictors of self-medication amongst street dwellers in Ethiopia: a multicentre study
Published 2024-01-01“…Drugs in Context…”
Get full text
Article -
5
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial
Published 2020-07-01“…Drugs in Context…”
Get full text
Article -
6
Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome
Published 2022-04-01“…Drugs in Context…”
Get full text
Article -
7
Nutritional support management in resectable gastric cancer
Published 2022-10-01“…Drugs in Context…”
Get full text
Article -
8
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Published 2018-11-01“…Drugs in Context…”
Get full text
Article -
9
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
Published 2020-04-01“…Drugs in Context…”
Get full text
Article -
10
Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
Published 2022-03-01“…Drugs in Context…”
Get full text
Article -
11
Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts
Published 2024-03-01“…Drugs in Context…”
Get full text
Article -
12
Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases
Published 2023-09-01“…Drugs in Context…”
Get full text
Article -
13
Coronavirus disease 2019 (COVID-19): latest developments in potential treatments
Published 2020-06-01“…Drugs in Context…”
Get full text
Article -
14
Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Published 2014-06-01“…Drugs in Context…”
Get full text
Article -
15
A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus
Published 2021-05-01“…Drugs in Context…”
Get full text
Article -
16
Necessity of vancomycin trough concentrations to manage uncomplicated acute bacterial skin and skin structure infections: a laboratory stewardship analysis
Published 2023-05-01“…Drugs in Context…”
Get full text
Article -
17
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study)
Published 2018-03-01“…Drugs in Context…”
Get full text
Article -
18
-
19
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations
Published 2014-04-01“…Drugs in Context…”
Get full text
Article -
20
Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
Published 2020-07-01“…Drugs in Context…”
Get full text
Article